Tran KA, Cheng MY, Mitra A, Ogawa H, Shi VY, Olney LP, . . . Maverakis E. (2015). MEK inhibitors and their potential in the treatment of advanced melanoma: The advantages of combination therapy. Dove Medical Press.
Chicago Style (17th ed.) CitationTran KA, Cheng MY, Mitra A, Ogawa H, Shi VY, Olney LP, Kloxin AM, and Maverakis E. MEK Inhibitors and Their Potential in the Treatment of Advanced Melanoma: The Advantages of Combination Therapy. Dove Medical Press, 2015.
MLA (9th ed.) CitationTran KA, et al. MEK Inhibitors and Their Potential in the Treatment of Advanced Melanoma: The Advantages of Combination Therapy. Dove Medical Press, 2015.
Warning: These citations may not always be 100% accurate.